Robert Schlaberg, MD, MPH

IDbyDNA Inc

Disclosure(s): IDBYDNA INC: Board Member, Employee, Explify-related IP, Stocks/Bonds

Poster(s):

• 526 - Antimicrobial Selection Based on Precision Metagenomics Compared with Standard Urine Culture/Susceptibility: A Reliability and Inter-rater Agreement Analysis for Application in Patients with Urinary Tract Infections
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET